<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">2741</id>
  <title>T3D2699</title>
  <common-name>Vitamin A</common-name>
  <description>Vitamin A (retinol) is a yellow fat-soluble, antioxidant vitamin important in vision and bone growth. It belongs to the family of chemical compounds known as retinoids. Retinol is ingested in a precursor form; animal sources (milk and eggs) contain retinyl esters, whereas plants (carrots, spinach) contain pro-vitamin A carotenoids. Hydrolysis of retinyl esters results in retinol while pro-vitamin A carotenoids can be cleaved to produce retinal. Retinal, also known as retinaldehyde, can be reversibly reduced to produce retinol or it can be irreversibly oxidized to produce retinoic acid. Retinol and derivatives of retinol that play an essential role in metabolic functioning of the retina, the growth of and differentiation of epithelial tissue, the growth of bone, reproduction, and the immune response. Dietary vitamin A is derived from a variety of carotenoids found in plants. It is enriched in the liver, egg yolks, and the fat component of dairy products.</description>
  <cas>68-26-8</cas>
  <pubchem-id>445354</pubchem-id>
  <chemical-formula>C20H30O</chemical-formula>
  <weight>286.229670</weight>
  <appearance>White powder.</appearance>
  <melting-point>63.5°C</melting-point>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility>0.671 mg/L</solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure>Oral, readily absorbed from the normal gastrointestinal tract</route-of-exposure>
  <target nil="true"/>
  <mechanism-of-toxicity>Vision:Vitamin A (all-&lt;i&gt;trans&lt;/i&gt; retinol) is converted in the retina to the 11-&lt;i&gt;cis&lt;/i&gt;-isomer of retinaldehyde or 11-&lt;i&gt;cis&lt;/i&gt;-retinal. 11-&lt;i&gt;cis&lt;/i&gt;-retinal functions in the retina in the transduction of light into the neural signals necessary for vision. 11-&lt;i&gt;cis&lt;/i&gt;-retinal, while attached to opsin in rhodopsin is isomerized to all-&lt;i&gt;trans&lt;/i&gt;-retinal by light. This is the event that triggers the nerve impulse to the brain which allows for the perception of light. All-&lt;i&gt;trans&lt;/i&gt;-retinal is then released from opsin and reduced to all-&lt;i&gt;trans&lt;/i&gt;-retinol. All-&lt;i&gt;trans&lt;/i&gt;-retinol is isomerized to 11-&lt;i&gt;cis&lt;/i&gt;-retinol in the dark, and then oxidized to 11-&lt;i&gt;cis&lt;/i&gt;-retinal. 11-&lt;i&gt;cis&lt;/i&gt;-retinal recombines with opsin to re-form rhodopsin. Night blindness or defective vision at low illumination results from a failure to re-synthesize 11-&lt;i&gt;cis&lt;/i&gt; retinal rapidly. &lt;br/&gt;Epithelial differentiation: The role of Vitamin A in epithelial differentiation, as well as in other physiological processes, involves the binding of Vitamin A to two families of nuclear retinoid receptors (retinoic acid receptors, RARs; and retinoid-X receptors, RXRs). These receptors function as ligand-activated transcription factors that modulate gene transcription. When there is not enough Vitamin A to bind these receptors, natural cell differentiation and growth are interrupted.</mechanism-of-toxicity>
  <metabolism>Hepatic. Retinol is conjugated with glucuronic acid; the B-glucuronide undergoes enterohepatic circulation and oxidation to retinol and retinoic acid. Retinoic acid undergoes decarboxylation and conjugation with glucuronic acid.Half Life: 1.9 hours</metabolism>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity>No indication of carcinogenicity to humans (not listed by IARC).</carcinogenicity>
  <use-source>For the treatment of vitamin A deficiency. Vitamin A helps regulate the immune system, which helps prevent or fight off infections by making white blood cells that destroy harmful bacteria and viruses.</use-source>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms>Acute toxicity (single ingestion of 7 500 RE or 25 000 IU per kg or more): Signs and symptoms may be delayed for 8 to 24 hours and include: increased intracranial pressure, headache, irritability, drowsiness, dizziness, lethargy, vomiting, diarrhea, bulging of fontanels in infants, diplopia, papilledema. Peeling of skin around mouth may be observed from 1 to several days after ingestion and may spread to the rest of the body.</symptoms>
  <treatment>The treatment of hypervitaminosis A consists of immediate withdrawal of the vitamin along with symptomatic and supportive treatment. (L1712)</treatment>
  <created-at type="dateTime">2009-07-21T20:26:11Z</created-at>
  <updated-at type="dateTime">2014-12-24T20:25:49Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>Vitamin_A</wikipedia>
  <uniprot-id></uniprot-id>
  <kegg-compound-id>C00473</kegg-compound-id>
  <omim-id>100640
103730
107740
115300
120930
124020
136880
146732
151675
155050
164320
175100
176300
176803
176870
180069
180090
180100
180230
180245
180250
180260
180280
180290
180380
222448
240150
277350
300008
300009
300102
308990
600073
600086
600281
600463
600768
601186
601617
601691
602630
603687
604232
604863
605072
606467
606530
606623
606990
607599
607849
608575
608604
608830
608989
610745
611474
611589
611596</omim-id>
  <chebi-id>17336</chebi-id>
  <biocyc-id>RETINOL</biocyc-id>
  <ctd-id nil="true"/>
  <stitch-id>Vitamin A</stitch-id>
  <drugbank-id>DB00162</drugbank-id>
  <pdb-id>RTL</pdb-id>
  <actor-id>3068</actor-id>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>[H]\C(CO)=C(\C)/C(/[H])=C(\[H])/C(/[H])=C(\C)/C(/[H])=C(\[H])C1=C(C)CCCC1(C)C</moldb-smiles>
  <moldb-formula>C20H30O</moldb-formula>
  <moldb-inchi>InChI=1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6+,12-11+,16-8+,17-13+</moldb-inchi>
  <moldb-inchikey>InChIKey=FPIPGXGPPPQFEQ-OVSJKPMPSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">286.4516</moldb-average-mass>
  <moldb-mono-mass type="decimal">286.229665582</moldb-mono-mass>
  <origin>Endogenous</origin>
  <state>Solid</state>
  <logp>5.68</logp>
  <hmdb-id>HMDB00305</hmdb-id>
  <chembl-id>CHEMBL986</chembl-id>
  <chemspider-id>393012</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference>&lt;p&gt;William Oroshnik, &amp;#8220;Synthesis of Vitamin A, intermediates and conversion thereof to Vitamin A.&amp;#8221; U.S. Patent US4092366, issued May, 1948.&lt;/p&gt;</synthesis-reference>
  <structure-image-caption nil="true"/>
</compound>
